| Income Statement | 2025-09-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Revenue | 13 | 29 | 576 | |
| Research and development | 13,352 | 13,588 | 13,084 | |
| General and administrative | 7,328 | 8,553 | 8,767 | |
| Total operating expenses | 20,680 | 22,141 | 21,851 | |
| Operating loss | -20,667 | -22,112 | -21,275 | |
| Interest expense | - | 354 | 256 | |
| Gain on change in fair value of warrant liability | - | - | 3,647 | |
| (loss) gain from equity method investment | -591 | 1,342 | -875 | |
| (loss) gain on changes in other fair value adjustments | -3 | 49 | 571 | |
| (loss) gain on change in fair value of warrant liability | -1,179 | -804 | - | |
| Interest expense | 362 | - | - | |
| Interest income | 1,027 | 1,323 | 1,763 | |
| Gain (loss) on disposal of assets | 3 | -9 | - | |
| Total other (expense) income | -1,105 | 1,547 | 4,850 | |
| (loss) income from operations | -21,772 | -20,565 | -16,425 | |
| Net (loss) income | - | -20,565 | -16,425 | |
| Basic (in shares) | 11,818,145 | 9,292,066 | 7,287,173 | |
| Basic (in usd per shares) | -1.84 | -2.21 | -2.25 | |
| Diluted (in shares) | 11,818,145 | 9,292,066 | 7,287,173 | |
| Diluted (in usd per shares) | -1.84 | -2.21 | -2.25 | |
PRECISION BIOSCIENCES INC (DTIL)
PRECISION BIOSCIENCES INC (DTIL)